# Hypofractionated Radiotherapy for Prostate Cancer

> **NCT02311049** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 346 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Hypofractionation

## Key facts

- **NCT ID:** NCT02311049
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-01
- **Primary completion:** 2020-06-14
- **Final completion:** 2020-06-14
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311049, "Hypofractionated Radiotherapy for Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02311049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*